BSE
SHILPAMED

SHILPA MEDICARE LTD.

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

SHILPA MEDICARE LTD. Stock Price

Vitals

Today's Low:
₹349.35
Today's High:
₹368.2
Open Price:
₹366
52W Low:
₹222.4
52W High:
₹468.6568
Prev. Close:
₹365.55
Volume:
35078

Company Statistics

Market Cap.:
₹21.08 billion
Book Value:
163.027
Revenue TTM:
₹9.70 billion
Operating Margin TTM:
21.79%
Gross Profit TTM:
₹6.00 billion
Profit Margin:
23.38%
Return on Assets TTM:
6.12%
Return on Equity TTM:
0%

Company Profile

SHILPA MEDICARE LTD. had its IPO on under the ticker symbol SHILPAMED.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. SHILPA MEDICARE LTD. has a staff strength of 0 employees.

Stock update

Shares of SHILPA MEDICARE LTD. opened at ₹366 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹349.35 - ₹368.2, and closed at ₹352.55.

This is a -3.56% slip from the previous day's closing price.

A total volume of 35,078 shares were traded at the close of the day’s session.

In the last one week, shares of SHILPA MEDICARE LTD. have slipped by -5.47%.

SHILPA MEDICARE LTD.'s Key Ratios

SHILPA MEDICARE LTD. has a market cap of ₹21.08 billion, indicating a price to book ratio of 1.4166 and a price to sales ratio of 2.2334.

In the last 12-months SHILPA MEDICARE LTD.’s revenue was ₹9.70 billion with a gross profit of ₹6.00 billion and an EBITDA of ₹2.56 billion. The EBITDA ratio measures SHILPA MEDICARE LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, SHILPA MEDICARE LTD.’s operating margin was 21.79% while its return on assets stood at 6.12% with a return of equity of 0%.

In Q4, SHILPA MEDICARE LTD.’s quarterly earnings growth was a positive 448.7% while revenue growth was a positive 38.4%.

SHILPA MEDICARE LTD.’s PE and PEG Ratio

Forward PE
0
Trailing PE
9.3635
PEG

Its diluted EPS in the last 12-months stands at ₹27.81 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SHILPA MEDICARE LTD.’s profitability.

SHILPA MEDICARE LTD. stock is trading at a EV to sales ratio of 2.9041 and a EV to EBITDA ratio of 19.3231. Its price to sales ratio in the trailing 12-months stood at 2.2334.

SHILPA MEDICARE LTD. stock pays annual dividends of ₹1.1 per share, indicating a yield of 0.42% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
₹29.83 billion
Total Liabilities
₹8.56 billion
Operating Cash Flow
₹0
Capital Expenditure
₹0
Dividend Payout Ratio
0%

SHILPA MEDICARE LTD. ended 2024 with ₹29.83 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹29.83 billion while shareholder equity stood at ₹17.97 billion.

SHILPA MEDICARE LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹8.56 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹456.23 million in goodwill. Its cash balance stood at ₹473.37 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹2.66 billion.

SHILPA MEDICARE LTD.’s total current assets stands at ₹9.09 billion while long-term investments were ₹0 and short-term investments were ₹155.05 million. Its net receivables were ₹3.75 billion compared to accounts payable of ₹1.78 billion and inventory worth ₹3.64 billion.

In 2024, SHILPA MEDICARE LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, SHILPA MEDICARE LTD. paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price
₹352.55
52-Week High
₹468.6568
52-Week Low
₹222.4
Analyst Target Price

SHILPA MEDICARE LTD. stock is currently trading at ₹352.55 per share. It touched a 52-week high of ₹468.6568 and a 52-week low of ₹468.6568. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹343.05 and 200-day moving average was ₹280.56 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 7500.4% of the company’s stock are held by insiders while 940.9% are held by institutions.

Frequently Asked Questions About SHILPA MEDICARE LTD.

The stock symbol (also called stock or share ticker) of SHILPA MEDICARE LTD. is SHILPAMED

The IPO of SHILPA MEDICARE LTD. took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
₹1686.65
-12.3
-0.72%
₹13.9
0.06
+0.43%
Kubient Inc (KBNT)
₹0.35
-0.03
-7.88%
₹1933.01
-15.84
-0.81%
₹0.37
-0.01
-2.11%
₹29.28
-0.13
-0.44%
₹7.51
0.4
+5.63%
₹1.99
0
0%
₹12.5
-0.49
-3.77%
₹0.05
0
0%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (API’s), intermediates, and formulations in India, the United States, Europe, and internationally.. It offers API’s for oncology and other therapeutic areas; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the generation and sale of wind power. Shilpa Medicare Limited was founded in 1987 and is headquartered in Raichur, India.

Address

Shilpa House, Raichur, India, 584135